Eppendorf, a leading life sciences company, is excited to announce a substantial new price point for its popular epMotion 5073 automated liquid handling system. This change reflects Eppendorf’s commitment to making liquid handling automation more attainable for all laboratories, supporting greater efficiency and consistency in everyday lab workflows without compromising on Eppendorf’s known superior quality [...]

Industry-first probes featuring computationally designed binding proteins provide unprecedented affinity, baseline stability, and data quality for antibody characterization and biologics research PALO ALTO, CA & Seattle, WA — Gator Bio, a pioneer in biolayer interferometry (BLI) technologies, today announced the commercial launch of its Gator HIS XT probes, the first biolayer interferometry probes to incorporate AI-designed binding [...]

MARCY-L'ÉTOILE, France -- bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of SMARTBIOME™, an innovative solution designed to help food manufacturers better understand, control and prevent microbiological spoilage. By combining high‑precision DNA sequencing, advanced bioinformatics and bioMérieux's microbiology expertise, SMARTBIOME™ provides actionable insights to protect product quality, reduce waste and better preserve [...]

New SciSure and Safety Partners partnership connects consulting EHS expertise with a unified digital lab platform to simplify compliance and enhance lab safety. SciSure, the Scientific Management Platform that unifies research operations, inventory, and EHS for research labs, today announced a strategic partnership with Safety Partners, part of Trinity Consultants Life Sciences and a leading [...]

3RnD® platform connects targets, compounds and authenticated human cell models to reduce manual searching and enable earlier, more informed R&D decisions By combining Cytion’s authenticated cell models with 3RnD’s data and AI workflow, we enable earlier, more reproducible and more actionable safety insight” — Jonathan Steubing, CEO, Cytion HEIDELBERG, BADEN-WüRTTEMBERG, GERMANY — Cytion, a trusted provider of [...]

BOULDER, Colo. -- Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, for certain foundational CRISPR-Cas9 intellectual property for use in NGS library preparation. While CRISPR-Cas9 technologies are most commonly associated with their unique ability to find [...]

Delivers up to 2× higher sensitivity than stainless steel microflow columns, lowering detection and quantitation limits across high-throughput bioseparations, DMPK, and 'omics applications.1  Uses up to 75% less sample than 2.1 mm I.D. columns, conserving precious materials such as cell and gene therapy and personalized medicine candidates while delivering deeper insights. 2  Reduces solvent consumption by up to [...]

B-Body® platform complements Twist’s antibody discovery offering enabling rapid, efficient and precise expression and discovery of complex bispecific antibody therapeutics Platform to power high-throughput characterization of bispecific antibodies to fuel AI-enabled and traditional drug discovery SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has [...]

Partnership will deliver AI-guided end-to-end workflow to access challenging membrane protein targets To de-risk and shorten path to critical structural and biophysical insights that inform structure-based drug design Cambridge, UK, Boston MA, USA and Villigen, Switzerland -- Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery [...]

STOCKHOLM, Sweden -- CubaseBio, a biotechnology company founded by pioneers in spatial biology, today announced it has secured €5.9 million in blended financing. The funding comprises a €2 million non-dilutive grant from the European Innovation Council (EIC) Transition program and €3.9 million in private capital and convertibles from Voima Ventures, Nordic Science Investments (NSI), Illumina Ventures, Almi invest, Life Science Invest and [...]